- Report
- September 2026
Global
From €4439EUR$4,799USD£3,704GBP
- Report
- September 2026
- 199 Pages
Global
From €3279EUR$3,545USD£2,736GBP
€3643EUR$3,939USD£3,040GBP
- Report
- September 2026
- 197 Pages
Global
From €3279EUR$3,545USD£2,736GBP
€3643EUR$3,939USD£3,040GBP
- Report
- September 2026
- 188 Pages
Global
From €3279EUR$3,545USD£2,736GBP
€3643EUR$3,939USD£3,040GBP
- Report
- September 2026
- 190 Pages
Global
From €3279EUR$3,545USD£2,736GBP
€3643EUR$3,939USD£3,040GBP
- Report
- September 2026
- 186 Pages
Global
From €3279EUR$3,545USD£2,736GBP
€3643EUR$3,939USD£3,040GBP
- Report
- January 2026
- 184 Pages
Global
From €3279EUR$3,545USD£2,736GBP
€3643EUR$3,939USD£3,040GBP
- Report
- November 2026
- 375 Pages
Global
From €5411EUR$5,850USD£4,516GBP
- Report
- September 2026
- 199 Pages
Global
From €3279EUR$3,545USD£2,736GBP
€3643EUR$3,939USD£3,040GBP
- Report
- February 2026
- 250 Pages
Global
From €4153EUR$4,490USD£3,466GBP
- Report
- August 2026
- 120 Pages
Global
From €4393EUR$4,750USD£3,666GBP
- Report
- December 2025
- 150 Pages
Global
From €4486EUR$4,850USD£3,744GBP
- Report
- July 2026
- 160 Pages
Global
From €3071EUR$3,320USD£2,563GBP
€3838EUR$4,150USD£3,203GBP
- Report
- July 2026
- 160 Pages
Global
From €3071EUR$3,320USD£2,563GBP
€3838EUR$4,150USD£3,203GBP
- Report
- July 2026
- 120 Pages
United States
From €4393EUR$4,750USD£3,666GBP
- Report
- June 2026
- 110 Pages
United States
From €4393EUR$4,750USD£3,666GBP
- Report
- January 2025
- 110 Pages
Global
From €5503EUR$5,950USD£4,593GBP
- Report
- November 2024
- 80 Pages
North America
From €4578EUR$4,950USD£3,821GBP
- Report
- October 2024
- 180 Pages
Global
From €4162EUR$4,500USD£3,473GBP
- Report
- June 2025
- 26 Pages
Global
From €2729EUR$2,950USD£2,277GBP

Contract dose manufacturing is a service provided by pharmaceutical companies to produce drugs and other pharmaceutical products. It involves the production of active pharmaceutical ingredients (APIs) and finished dosage forms (FDFs) for customers. Contract dose manufacturing is a cost-effective way for pharmaceutical companies to outsource the production of their products. It also allows them to focus on their core competencies, such as research and development, while leaving the manufacturing to a third-party. Contract dose manufacturing is a highly regulated process, with strict quality control measures in place to ensure the safety and efficacy of the products.
Some of the companies in the contract dose manufacturing market include Boehringer Ingelheim, Catalent, Lonza, Patheon, Recipharm, and Vetter. Show Less Read more